Bladder Cancer Trial, Recruiting (NCT07088536)

Bladder Cancer Trial, Recruiting NCT07088536 Sponsor: Jagiellonian University Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07088536 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older who are admitted to the Department of Urology and Oncological Urology at the University Hospital in Kraków during the 6-month study period.
People who are currently employed at the time of entering the study (for the follow-up part of the trial).
People who are scheduled to have a major urological cancer operation (such as removal of the bladder, prostate, or kidney) or a procedure to treat kidney or urinary tract stones (for the follow-up part of the trial).
People who are able and willing to sign a written consent form agreeing to take part.

Who may not be able to join:

People who are unwilling or unable to sign a consent form agreeing to take part.
People who are unemployed or retired at the time of entering the study — these individuals would not be eligible for the follow-up part of the trial, though they may still be able to take part in the one-time survey portion (confirm with trial site).
People who are not scheduled to have a major urological cancer operation or a kidney/urinary tract stone procedure would not be eligible for the follow-up part of the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48124002500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07088536

Sponsor: Jagiellonian University

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +48124002500

More information: https://clinicaltrials.gov/study/NCT07088536

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older who are admitted to the Department of Urology and Oncological Urology at the University Hospital in Kraków during the 6-month study period.
People who are currently employed at the time of entering the study (for the follow-up part of the trial).
People who are scheduled to have a major urological cancer operation (such as removal of the bladder, prostate, or kidney) or a procedure to treat kidney or urinary tract stones (for the follow-up part of the trial).
People who are able and willing to sign a written consent form agreeing to take part.

Who may not be able to join:

People who are unwilling or unable to sign a consent form agreeing to take part.
People who are unemployed or retired at the time of entering the study — these individuals would not be eligible for the follow-up part of the trial, though they may still be able to take part in the one-time survey portion (confirm with trial site).
People who are not scheduled to have a major urological cancer operation or a kidney/urinary tract stone procedure would not be eligible for the follow-up part of the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Jagiellonian University

Registry

ClinicalTrials.gov

Start date

21 July 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Occupational Status of Patients With Urological Diseases; Return to Work Rate in Occupationally Active Patients Undergoing Major Uro-Oncological Surgeries; Return to Work Rate in Occupationally Active Patients Undergoing Procedures for Urinary Tract Stones

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov